GPR19 Antikörper

Produktnummer ABIN2665009

Produktdetails anti-GPR19 Antikörper

Target: GPR19 (G Protein-Coupled Receptor 19 (GPR19))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser GPR19 Antikörper ist unkonjugiert

Applikation: Immunofluorescence (IF), Flow Cytometry (FACS), ELISA (Detection), ELISpot (Detection) (ELISPOT (Detection)), Intracellular Flow Cytometry (ICFC)

Aufreinigung: The antibody was purified by affinity chromatography.

Klon: K152D10

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: The antibody solution should be stored undiluted between 2°C and 8°C.

Details zu GPR19

Target: GPR19 (G Protein-Coupled Receptor 19 (GPR19))

Andere Bezeichnung: GPR19 (GPR19 Produkte)

Synonyme: zgc:63912 antikoerper, G protein-coupled receptor 19 antikoerper, GPR19 antikoerper, Gpr19 antikoerper, gpr19 antikoerper

Hintergrund: GPR19 is a 415 amino acid protein with two potential glycosylation sites and one disulfide bond that belongs to Orphan G-protein-coupled receptors (GPCRs) with unknown ligand. In mice, GPR19 is highly expressed in the nervous system during embryonic development as well as in specific regions of the mouse adult brain, including the olfactory bulb, the hippocampus, the hypothalamic nuclei, and the cerebellum. It shows low levels of expression in the heart, liver, and kidney. In humans, GPR19 has been reported in regions overlapping with the dopamine D2 receptor in the brain and peripheral nervous system. It was also found in human embryonic stem cells. GPR19 gene was reported to be overexpressed with small cell lung cancer and metastatic melanomas.